L95.1
Erythema elevatum diutinum
Clinical Classification Guidelines
Medical Intelligence & Overview
Erythema elevatum diutinum (EED) is a rare chronic skin condition characterized by the development of firm, raised, and often reddish or purple lesions primarily on the skin's surface. These lesions tend to appear on the extensor surfaces of joints, such as the elbows, knees, and sometimes the hands or feet. Though uncommon, EED is notable for its persistent nature and its association with other systemic conditions. Awareness and understanding of this condition are essential for proper diagnosis and management.
Causes & Symptoms
Clinical Causes: Chronic immune system activation that leads to inflammation of small blood vessels in the skin. Association with systemic conditions such as hematological disorders, including monoclonal gammopathies and leukemia. In some cases, it has been linked to infections, such as streptococcal infections or hepatitis. Potential genetic predispositions that may influence immune responses.
Key Symptoms: Raised, firm nodules or plaque-like lesions that are often reddish, violaceous, or purple in color. Lesions are usually symmetrical and located on the extensor surfaces of joints like the elbows and knees. Lesions may become ulcerated or develop a crust over time. In some cases, lesions are asymptomatic but can be tender or painful to touch. Potential skin thickening or contractures if the condition persists over time.
Diagnostic & Treatment
Diagnosis Path: Diagnosis primarily involves a clinical examination of the characteristic skin lesions combined with a detailed medical history. Laboratory tests, including blood work, may reveal associated systemic conditions or underlying immune activity. A skin biopsy is often performed to confirm the diagnosis, showing characteristic features such as leukocytoclastic vasculitis with fibrinoid necrosis of vessel walls. Additional tests might include immunofluorescence for immune complex deposits and investigations for systemic diseases linked to EED.
Treatment Protocols: Managing erythema elevatum diutinum involves a combination of approaches tailored to the individual's condition. Common treatments include topical and systemic therapies aimed at reducing inflammation and controlling associated systemic diseases. Treatments may involve: - **Dapsone**: A medication frequently used for its anti-inflammatory and immunomodulating effects. - **Corticosteroids**: Topical or systemic steroids to decrease inflammation. - **Immunosuppressive agents**: Such as colchicine or other drugs if indicated. - **Treating underlying conditions**: Addressing systemic disorders like hematological abnormalities can help improve skin lesions. - Regular follow-up and monitoring are essential to assess response to therapy and manage any complications.
Clinical Advice & FAQs
Billing Guidance
Is L95.1 a billable ICD-10 code?
Yes, L95.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report L95.1?
Clinical documentation must specify the nature of Erythema elevatum diutinum and any associated comorbidities for accurate reporting.
Cite this Clinical Reference